Ali Moshfegh
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- CAR-T cell therapy research
- Hematology top 5%
- Acute Myeloid Leukemia Research
Papers in
-
- Wnt/β-catenin signaling in development and cancer 9
- PI3K/AKT/mTOR signaling in cancer 9
- Immunology 17
- Galectins and Cancer Biology 5
- Immune Cell Function and Interaction 5
- Co-authors
- Håkan Mellstedt (26 shared papers)Vladimir J.N. Bykov (2 shared papers)Klas G. Wiman (2 shared papers)Mohammad Hojjat‐Farsangi (23 shared papers)Joachim Lundahl (11 shared papers)Anders Österborg (18 shared papers)Amir Hossein Daneshmanesh (15 shared papers)Ulf Tidefelt (1 shared paper)
In The Last Decade
Ali Moshfegh
61 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 101
- Oncology 471
- Hematology 169
- Cancer Research 204
- Immunology 277
- Genetics 114
Countries citing papers authored by Ali Moshfegh
This map shows the geographic impact of Ali Moshfegh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Moshfegh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Moshfegh more than expected).
Fields of papers citing papers by Ali Moshfegh
This network shows the impact of papers produced by Ali Moshfegh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Moshfegh. The network helps show where Ali Moshfegh may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali Moshfegh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 326 | |
| 2 | 2012 | 101 | |
| 3 | 2009 | 85 | |
| 4 | 2014 | 83 | |
| 5 | 2007 | 74 | |
| 6 | 2004 | 62 | |
| 7 | 2013 | 52 | |
| 8 | 2007 | 49 | |
| 9 | 2018 | 43 | |
| 10 | 2018 | 34 | |
| 11 | 2020 | 31 | |
| 12 | 2015 | 30 | |
| 13 | 2010 | 28 | |
| 14 | 2017 | 28 | |
| 15 | 2016 | 26 | |
| 16 | 1998 | 24 | |
| 17 | 2015 | 24 | |
| 18 | 2016 | 23 | |
| 19 | 2013 | 22 | |
| 20 | 2009 | 22 |
About Ali Moshfegh
Ali Moshfegh is a scholar working on Molecular Biology, Immunology, Oncology, Genetics and Hematology, having authored 61 papers that have together received 1.5k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (11 papers), Wnt/β-catenin signaling in development and cancer (9 papers), PI3K/AKT/mTOR signaling in cancer (9 papers), Galectins and Cancer Biology (5 papers), Asthma and respiratory diseases (5 papers), Immune Cell Function and Interaction (5 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Dialysis and Renal Disease Management (4 papers). The work is most often cited by research in Oncology (471 citations), Hematology (169 citations), Cancer Research (204 citations), Immunology (277 citations) and Genetics (114 citations). Ali Moshfegh has collaborated with scholars based in Sweden, Iran and Canada. Frequent co-authors include Håkan Mellstedt, Vladimir J.N. Bykov, Klas G. Wiman, Mohammad Hojjat‐Farsangi, Joachim Lundahl, Anders Österborg, Amir Hossein Daneshmanesh, Ulf Tidefelt, Honar Cherif and Dina Ali. Their work appears in journals such as PLoS ONE, Blood, Journal of Clinical Oncology, Biochemical Pharmacology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.